APLS Q2 2021 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$3B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$623,000

Gross Profit

$623,000100.0% margin

Operating Income

-$194M-31185.7% margin

Net Income

-$219M-35183.1% margin

EPS (Diluted)

$-2.72

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$129M

Free Cash Flow

-$129M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$700M

Total Liabilities

$841M

Stockholders' Equity

-$141M

Cash & Equivalents

$271M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$623,000	$0	—
Gross Profit	$623,000	-$122,000	+610.7%
Operating Income	-$194M	-$116M	-68.2%
Net Income	-$219M	-$119M	-84.8%